Keywords
Skyrizi,Plaque psoriasis,psoriatic arthritis,Crohn's disease,interleukin 23A,IL-23A,IL-23,cho cell,mutation,mutant,mutated,Leu234Ala,Leu235Ala,lala mutation,double mutation,subcutaneous injection,injection,autoinjection,monoclonal antibody,antibody,antibody drug,antibody drug,drug,antigen,competitor,immunologlobulin,binding agent,monoclonal,immune,immunoglobin,immunological,antigen-binding,nanobody,fabs,neutralizing,polyclonal,therapeutic,immunology,oncology,biochemistry,molecular biology,pharmacology,biotechnology,injector,auto injector,auto-injector,autoinjector,injector device,injector pen,inject,auto syringe,self-injectable,injectable,medication pen,medication,pen,uncapped,needle,metabolic,syndrome,treatment,treat,therapy,tip,medicine,plunger,dose window,selection,dial,dose,disposable,button,chemotherapy,chemo,cancer,at-home,one-use,spring-loaded syringes,syringe,actuator,self-administration,drug delivery,prefilled syringe,intramuscular,subcutaneous,single use,epinephrine,insulin pen,portable injector,Humira,rheumatoid arthritis,psoriasis,Crohn's disease,epipen,medical device,medical equipment,medical instrument,medical apparatus,medical tool,medical appliance,proj-creative-abx-24q2,proj-creative-abx-24q2-AbbVie,Skyrizi,risankizumab,injector pen